| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 441.38B | 401.99B | 367.65B | 373.15B | 366.16B |
| Gross Profit | 206.02B | 172.95B | 153.50B | 171.08B | 166.86B |
| EBITDA | 67.76B | 64.20B | 55.93B | 63.20B | 67.55B |
| Net Income | 40.46B | 36.55B | 28.15B | 34.28B | 37.56B |
Balance Sheet | |||||
| Total Assets | 464.97B | 419.57B | 413.52B | 378.46B | 347.39B |
| Cash, Cash Equivalents and Short-Term Investments | 112.94B | 159.30B | 148.85B | 119.56B | 108.89B |
| Total Debt | 8.77B | 7.54B | 6.82B | 7.68B | 7.18B |
| Total Liabilities | 82.46B | 67.51B | 65.83B | 64.23B | 67.43B |
| Stockholders Equity | 381.13B | 350.95B | 346.60B | 313.28B | 279.16B |
Cash Flow | |||||
| Free Cash Flow | 37.90B | 45.03B | 36.59B | 17.82B | 38.88B |
| Operating Cash Flow | 52.19B | 60.46B | 54.57B | 31.45B | 55.39B |
| Investing Cash Flow | -43.20B | -32.45B | -19.00B | -19.00B | -22.76B |
| Financing Cash Flow | -41.80B | -31.76B | -18.97B | -11.20B | -9.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥917.36B | 10.13 | 9.10% | 1.63% | 9.80% | 13.15% | |
78 Outperform | ¥271.75B | 25.26 | ― | 1.17% | 23.18% | 15.70% | |
74 Outperform | ¥301.50B | 11.92 | 7.86% | 2.55% | 5.68% | 41.20% | |
66 Neutral | ¥425.38B | 55.37 | 11.46% | 3.77% | 2.76% | 56.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥120.11B | 26.06 | 2.64% | 2.30% | 0.90% | 15.74% | |
50 Neutral | ¥237.45B | 85.52 | -4.83% | 3.08% | -2.15% | -121.31% |